Please login to the form below

Not currently logged in
Email:
Password:

ABT-530

This page shows the latest ABT-530 news and features for those working in and with pharma, biotech and healthcare.

AbbVie hepatitis C combo shows high cure rates

AbbVie hepatitis C combo shows high cure rates

The new phase II data on NS3/4A protease inhibitor ABT-493 and NS5A inhibitor ABT-530 - which recently started pivotal trials - showed that 97-98% of patients with genotype ... AbbVie is hoping to be able to show that ABT-493/ABT-530 can achieve high

Latest news

  • AbbVie takes 'one-size-fits-all' HCV regimen into phase III AbbVie takes 'one-size-fits-all' HCV regimen into phase III

    The co-formulated drug - which combines NS3/4A protease inhibitor ABT-493 with NS5A inhibitor ABT-530 - will be tested in six phase III trials involving patients with HCV genotypes

  • Hepatitis C therapies: dawn of a new age Hepatitis C therapies: dawn of a new age

    AbbVie is developing a DAA-based, IFN-free regimen centred on the protease inhibitor ABT 450. ... AbbVie is co-formulating its next-generation compounds ABT 530 and ABT 493, its ritonavir-free protease inhibitor, and Gilead has GS 5816 poised for phase 3

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics